News Image

Why NYSE:DOCS Is a Standout High-Growth Stock in a Consolidation Phase.

By Mill Chart

Last update: Oct 24, 2023

Growth investors are on the lookout for stocks displaying robust revenue and EPS growth. In this analysis, we'll assess whether DOXIMITY INC-CLASS A (NYSE:DOCS) aligns with growth investing criteria, especially as it consolidates and signals a possible breakout. As always, investors should conduct their own research, but DOXIMITY INC-CLASS A has surfaced on our radar for growth with base formation, warranting further examination.

How We Gauge Growth for NYSE:DOCS

Every stock receives a Growth Rating from ChartMill, ranging from 0 to 10. This rating assesses various growth aspects, including historical and projected EPS and revenue growth. NYSE:DOCS boasts a 8 out of 10:

  • DOCS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 105.66% yearly.
  • DOCS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 53.27% yearly.
  • Based on estimates for the next years, DOCS will show a very strong growth in Earnings Per Share. The EPS will grow by 24.26% on average per year.
  • Based on estimates for the next years, DOCS will show a very strong growth in Revenue. The Revenue will grow by 21.10% on average per year.

A Closer Look at Health for NYSE:DOCS

A critical element of ChartMill's stock evaluation is the Health Rating, which spans from 0 to 10. This rating considers multiple health factors, including liquidity and solvency, both in absolute terms and relative to industry peers. NYSE:DOCS has received a 9 out of 10:

  • DOCS has an Altman-Z score of 17.86. This indicates that DOCS is financially healthy and has little risk of bankruptcy at the moment.
  • DOCS has a better Altman-Z score (17.86) than 95.35% of its industry peers.
  • DOCS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
  • A Current Ratio of 7.46 indicates that DOCS has no problem at all paying its short term obligations.
  • DOCS's Current ratio of 7.46 is amongst the best of the industry. DOCS outperforms 88.37% of its industry peers.
  • A Quick Ratio of 7.46 indicates that DOCS has no problem at all paying its short term obligations.
  • DOCS has a better Quick ratio (7.46) than 90.70% of its industry peers.

A Closer Look at Profitability for NYSE:DOCS

ChartMill employs its own Profitability Rating system for stock evaluation. This score, ranging from 0 to 10, is derived from an analysis of diverse profitability metrics and margins. In the case of NYSE:DOCS, the assigned 9 is noteworthy for profitability:

  • DOCS has a Return On Assets of 10.30%. This is amongst the best in the industry. DOCS outperforms 97.67% of its industry peers.
  • DOCS has a Return On Equity of 11.99%. This is amongst the best in the industry. DOCS outperforms 97.67% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 11.05%, DOCS belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for DOCS is significantly above the industry average of 3.74%.
  • The last Return On Invested Capital (11.05%) for DOCS is well below the 3 year average (17.24%), which needs to be investigated, but indicates that DOCS had better years and this may not be a problem.
  • DOCS has a Profit Margin of 27.20%. This is amongst the best in the industry. DOCS outperforms 95.35% of its industry peers.
  • DOCS's Profit Margin has improved in the last couple of years.
  • DOCS has a Operating Margin of 30.47%. This is amongst the best in the industry. DOCS outperforms 100.00% of its industry peers.
  • In the last couple of years the Operating Margin of DOCS has grown nicely.
  • DOCS has a better Gross Margin (87.74%) than 95.35% of its industry peers.

Looking at the Setup

In addition to the Technical Rating, ChartMill provides a Setup Rating for each stock. This rating, ranging from 0 to 10, assesses the extent of consolidation in the stock based on multiple short-term technical indicators. Currently, NYSE:DOCS has a 7 as its setup rating:

DOCS has a bad technical rating, but it does show a decent setup pattern. Prices have been consolidating lately and the volatility has been reduced. A pullback is taking place, which may present a nice opportunity for an entry. We notice that large players showed an interest for DOCS in the last couple of days, which is a good sign.

Our Strong Growth screener lists more Strong Growth stocks and is updated daily.

Check the latest full fundamental report of DOCS for a complete fundamental analysis.

Check the latest full technical report of DOCS for a complete technical analysis.

Disclaimer

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.

Back

DOXIMITY INC-CLASS A

NYSE:DOCS (4/19/2024, 7:04:00 PM)

After market: 24.6 -0.03 (-0.12%)

24.63

-0.19 (-0.77%)

DOCS News

News Image11 hours ago - Kahn Swick & Foti, LLCDOXIMITY SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Doximity, Inc. - DOCS
News Image17 hours ago - The Law Offices of Frank R. CruzThe Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Doximity, Inc. (DOCS) Investors
News Imagea day ago - Bronstein, Gewirtz & Grossman, LLCDOCS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Doximity, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

/PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has...

News Imagea day ago - Schall LawSHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Doximity, Inc. with Losses to Contact the Firm
News Image2 days ago - Bernstein Liebhard LLPDOXIMITY, INC. (NYSE: DOCS) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Doximity, Inc.
News Image2 days ago - Kessler Topaz Meltzer & Check, LLPClass Action Announcement (DOCS): Kessler Topaz Meltzer & Check, LLP Has Filed A Securities Fraud Class Action Lawsuit Against Doximity, Inc.

/PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit...

News Image2 days ago - Robbins Geller Rudman & Dowd LLPDOCS INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Doximity, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Image2 days ago - Bragar Eagel & SquireDOXIMITY ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Doximity, Inc. and Encourages Investors to Contact the Firm
News Image2 days ago - Robbins LLPStockholder Alert: Robbins LLP Informs Investors of the Class Action Filed Against Doximity, Inc. (DOCS)
News Image3 days ago - Kessler Topaz Meltzer & Check, LLPInvestor Alert: Kessler Topaz Meltzer & Check, LLP Files a Securities Fraud Class Action Lawsuit Against Doximity, Inc. and Encourages Investors With Losses to Contact the Firm (NYSE: DOCS)
News Image5 days ago - ChartmillFor those who appreciate growth without the sticker shock, NYSE:DOCS is worth considering.

DOXIMITY INC-CLASS A (NYSE:DOCS) stands out as a growth opportunity that won't break the bank.

News Image8 days ago - Pomerantz LLPSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Doximity, Inc. ("Doximity" or the "Company") (NYSE: DOCS). Such investors are...

DOCS Links
Follow us for more